Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
State Street Energy Select Sector SPDR ETF
XLE
$41.5B
| $12.1M | 0.02% |
359,464
+172,588
| +92% | +$6.11M |
|
|
DNR
1202
DELISTED
Denbury Resources, Inc.
DNR
| $12.1M | 0.02% |
4,416,547
+1,005,671
| +29% | +$2.37M |
|
1203
Avery Dennison
AVY
$13.9B
| $12.1M | 0.02% |
113,810
+32,287
| +40% | +$3.74M |
|
|
BECN
1204
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $12.1M | 0.02% |
227,827
-1,271,291
| -85% | -$73.1M |
|
|
CPE
1205
DELISTED
Callon Petroleum Company
CPE
| $12.1M | 0.02% |
91,288
+63,321
| +226% | +$7.43M |
|
|
ITCI
1206
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.1M | 0.02% |
573,968
-880,976
| -61% | -$17.2M |
|
|
APC
1207
CALL
DELISTED
Anadarko Petroleum
APC
| $12.1M | 0.02% |
+200,000
| New | +$11.7M |
|
1208
iShares Core S&P 500 ETF
IVV
$891B
| $12.1M | 0.02% |
45,484
-38,069
| -46% | -$10.5M |
|
|
CVG
1209
DELISTED
Convergys
CVG
| $12.1M | 0.02% |
533,322
+335,092
| +169% | +$7.68M |
|
1210
Provident Financial Services
PFS
$3.07B
| $12.1M | 0.02% |
471,294
+127,776
| +37% | +$3.36M |
|
|
AVEO
1211
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $12.1M | 0.02% |
415,609
+142,904
| +52% | +$4.18M |
|
|
TIVO
1212
DELISTED
Tivo Inc
TIVO
| $12M | 0.02% |
888,970
+316,946
| +55% | +$4.52M |
|
1213
Ionis Pharmaceuticals
IONS
$10.3B
| $12M | 0.02% |
272,837
+76,920
| +39% | +$3.91M |
|
|
EXTN
1214
DELISTED
Exterran Corporation
EXTN
| $12M | 0.02% |
450,273
+221,808
| +97% | +$6.42M |
|
|
TPIC
1215
DELISTED
TPI Composites
TPIC
| $12M | 0.02% |
534,255
-81,909
| -13% | -$1.68M |
|
1216
Exelon
EXC
$45.7B
| $12M | 0.02% |
430,710
-3,482,983
| -89% | -$94M |
|
1217
Koppers
KOP
$867M
| $12M | 0.02% |
291,279
+204,402
| +235% | +$8.99M |
|
|
INFN
1218
DELISTED
Infinera Corporation Common Stock
INFN
| $11.9M | 0.02% |
1,099,867
+1,001,790
| +1,021% | +$8.88M |
|
1219
Kulicke & Soffa
KLIC
$4.37B
| $11.9M | 0.02% |
477,382
-980,668
| -67% | -$23.6M |
|
|
KDNY
1220
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.9M | 0.02% |
256,469
+196,781
| +330% | +$7.2M |
|
|
WWE
1221
DELISTED
World Wrestling Entertainment
WWE
| $11.9M | 0.02% |
331,099
-556,505
| -63% | -$19.6M |
|
|
VIVO
1222
DELISTED
Meridian Bioscience Inc
VIVO
| $11.9M | 0.02% |
839,609
-294,156
| -26% | -$4.35M |
|
1223
Black Hills Corp
BKH
$5.49B
| $11.9M | 0.02% |
219,348
-268,083
| -55% | -$14.3M |
|
|
AVP
1224
DELISTED
Avon Products, Inc.
AVP
| $11.9M | 0.02% |
4,184,563
-4,650,955
| -53% | -$11.8M |
|
|
VISN
1225
Vistance Networks Inc
VISN
$2.5B
| $11.9M | 0.02% |
296,677
-26,100
| -8% | -$1.02M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.